9SC-22686-55143
3 vaccinations
4 coded responses
25 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 975 / OR
- Registered
- 2021-02-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-17
Registered in v-safe
-
2021-02-17
Dose 1 — Pfizer-BioNTech
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-03
-
2021-03-10
Survey response — day 21, dose 1MedDRA: Arthralgia, Eye pain, Headache, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Bilateral eye pain, without redness/discharge, headache, fever, joint pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Report sent to call center — day 21, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-16
Dose 2 — Pfizer-BioNTech
-
2021-03-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-22
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-04-29
- 2021-06-15
-
2021-09-16
Survey response — 6 months, dose 2MedDRA: Dyspnoea, Exposure to SARS-CoV-2, Pyrexia — Feeling: GoodFree text: Week of low grade fevers and couple weeks of shortness of breath following several hours of COVID-19 exposure. Tested negative.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-22
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-03-01
-
2022-05-23
Survey response — 6 months, dose 3MedDRA: Asthenia, COVID-19, Chest pain, Cough, Fatigue, Malaise, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Contracted Covid and was sick for approximately 2-3 weeks with fever, cough, fatigue and weakness . Experienced atypical chest pain for 1 week. Resolved now.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-23
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-05-24
- 2022-05-24
-
2022-11-22
Survey response — 12 months, dose 3MedDRA: COVID-19, Chest pain, No reaction on previous exposure to drug, Pain, Pyrexia — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Week of intermittent sternal chest pain with Covid infection and occasional reoccurrence in the subsequent months. Fever and body aches following last booster which was 4th in the series. First time symptomatic following a vaccination.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-22
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2022-11-23
Call successfulParticipant prefers to complete VAERS report online
-
2022-11-23
Call successfulParticipant prefers to complete VAERS report online
-
2022-11-23
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-17 | Pfizer-BioNTech | |
| 2 | 2021-03-16 | Pfizer-BioNTech | |
| 3 | 2021-11-22 | Pfizer-BioNTech | Flu |
Call center
3 call center cases
3 successful
1 wait over 3 months for a first call
Free text
Release 5 — day 21, dose 1
Symptoms: Bilateral eye pain, without redness/discharge, headache, fever, joint pain.
Release 9 — 6 months, dose 2
Symptoms: Week of low grade fevers and couple weeks of shortness of breath following several hours of COVID-19 exposure. Tested negative.
Release 11 — 6 months, dose 3
Symptoms: Contracted Covid and was sick for approximately 2-3 weeks with fever, cough, fatigue and weakness . Experienced atypical chest pain for 1 week. Resolved now.
Release 12 — 12 months, dose 3
Symptoms: Week of intermittent sternal chest pain with Covid infection and occasional reoccurrence in the subsequent months. Fever and body aches following last booster which was 4th in the series. First time symptomatic following a vaccination.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Eye pain | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | No reaction on previous exposure to drug | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release